Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Serbia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20071
20081
20101
20111
20121
20142
20163
20171
20181
20202
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S6
Intra-Cellular Therapies, Inc.2
Janssen Research & Development, LLC2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Sanofi2
AbbVie1
AstraZeneca1
Corcept Therapeutics1
Neurocrine Biosciences1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder20
Depressive Disorder4
Mood Disorders3
Mental Disorders2
Bipolar Disorder1
Dysthymic Disorder1
Psychotic Disorders1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.